Novartis has 25 blockbusters in the pipeline - CEO

Credit: REUTERS/ARND WIEGMANN

ZURICH, May 23 (Reuters) - Novartis NOVN.S has 25 potential blockbuster treatments in development, the company said ahead of a management event in the United States on Thursday.

"Our pipeline is industry-leading with more than 25 potential blockbusters and this pace of innovation positions Novartis well for the future", said Novartis Chief Executive Vas Narasimhan in a statement.

(Reporting by Silke Koltrowitz)

((silke.koltrowitz@thomsonreuters.com; +41 58 306 7454; Reuters Messaging: silke.koltrowitz.thomsonreuters.com@reuters.net))

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

More Related Articles

Info icon

This data feed is not available at this time.

Sign up for Smart Investing to get the latest news, strategies and tips to help you invest smarter.